Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum

By Westerink B.H.C.   Kawahara Y.   De Boer P.   Geels C.   De Vries J.B.   Wikstrom H.V.   Van Kalkeren A.   Van Vliet B.   Kruse C.G.   Long S.K.  

European Journal of Pharmacology, Vol. 412, Iss. 2, 2001-01 ,pp. : 127-138

Elsevier

Access to resources Recommend Favorite

Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat

By Skarsfeldt T.  

European Journal of Pharmacology, Vol. 281, Iss. 3, 1995-08 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite

Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain

By Westerink B.H.C.   de Boer P.   de Vries J.B.   Kruse C.G.   Long S.K.  

European Journal of Pharmacology, Vol. 361, Iss. 1, 1998-11 ,pp. : 27-33

Elsevier

Access to resources Recommend Favorite

Electrophysiological effects of E-5842, a 1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons

By Sanchez-Arroyos R.   Guitart X.  

European Journal of Pharmacology, Vol. 378, Iss. 1, 1999-07 ,pp. : 31-37

Elsevier

Access to resources Recommend Favorite

Cardiovascular Adverse Effects of Antipsychotic Drugs

By Buckley N.A.  

Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. : 215-228

Adis International

Access to resources Recommend Favorite